A detailed history of Jpmorgan Chase & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Jpmorgan Chase & CO holds 18,174,386 shares of LLY stock, worth $14.5 Billion. This represents 1.32% of its overall portfolio holdings.

Number of Shares
18,174,386
Previous 18,838,691 3.53%
Holding current value
$14.5 Billion
Previous $17.1 Billion 5.6%
% of portfolio
1.32%
Previous 1.5%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$772.14 - $960.02 $513 Million - $638 Million
-664,305 Reduced 3.53%
18,174,386 $16.1 Billion
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $264 Million - $331 Million
-364,272 Reduced 1.9%
18,838,691 $17.1 Billion
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $41.9 Million - $56 Million
-70,722 Reduced 0.37%
19,202,963 $14.9 Billion
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $1.82 Billion - $2.15 Billion
3,470,493 Added 21.96%
19,273,685 $11.2 Billion
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $723 Million - $997 Million
1,663,578 Added 11.77%
15,803,192 $8.49 Billion
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $1.13 Billion - $1.51 Billion
3,228,109 Added 29.58%
14,139,614 $6.63 Billion
Q1 2023

May 18, 2023

BUY
$310.63 - $364.82 $115 Million - $135 Million
371,158 Added 3.52%
10,911,505 $3.75 Billion
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $1.7 Billion - $2 Billion
-5,479,314 Reduced 34.2%
10,540,347 $3.62 Billion
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $406 Million - $473 Million
1,261,226 Added 8.55%
16,019,661 $5.86 Billion
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $218 Million - $249 Million
-736,640 Reduced 4.75%
14,758,435 $4.77 Billion
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $223 Million - $262 Million
-801,157 Reduced 4.92%
15,495,075 $5.02 Billion
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $165 Million - $205 Million
-701,646 Reduced 4.13%
16,296,232 $4.67 Billion
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $295 Million - $366 Million
1,312,944 Added 8.37%
16,997,878 $4.7 Billion
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $3.48 Billion - $4.28 Billion
15,684,934 New
15,684,934 $3.62 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.